We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.25%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$76.2B
AUM Growth
+$3.6B
(+5%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
46.27%
Holding
781
New
70
Increased
299
Reduced
299
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$510M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 3 |
Builders FirstSource
BLDR
|
+$110M |
| 4 |
Amazon
AMZN
|
+$91.9M |
| 5 |
Natixis Loomis Sayles Focused Growth ETF
LSGR
|
+$77.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$114M |
| 2 |
Meta Platforms (Facebook)
META
|
+$87.2M |
| 3 |
Netflix
NFLX
|
+$77.3M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$65.6M |
| 5 |
Accenture
ACN
|
+$58.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.59% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Communication Services | 17.38% |
| 4 | Healthcare | 13.08% |
| 5 | Financials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Yum China
YUMC
$16.3B
| $243M | 0.32% |
5,407,008
-319,439
| -6% | -$10.6M |
|
52
JPMorgan Chase
JPM
$950B
| $228M | 0.3% |
1,082,967
-75,033
| -6% | -$15.8M |
|
53
Cummins
CMI
$88.7B
| $222M | 0.29% |
684,893
+12,026
| +2% | +$3.56M |
|
54
TSMC
TSM
$2.18T
| $214M | 0.28% |
1,231,973
+10,966
| +0.9% | +$1.87M |
|
55
Goldman Sachs
GS
$303B
| $187M | 0.25% |
377,334
+5,867
| +2% | +$2.87M |
|
56
Mercado Libre
MELI
$92.3B
| $183M | 0.24% |
89,222
-7,398
| -8% | -$13.9M |
|
57
IQVIA
IQV
$39.3B
| $165M | 0.22% |
696,700
-71,337
| -9% | -$16.8M |
|
|
58
Accenture
ACN
$108B
| $152M | 0.2% |
429,430
-178,936
| -29% | -$58.8M |
|
59
Adobe
ADBE
$105B
| $150M | 0.2% |
290,436
+4,524
| +2% | +$2.48M |
|
60
Alnylam Pharmaceuticals
ALNY
$29.3B
| $144M | 0.19% |
525,303
-43,979
| -8% | -$11.5M |
|
61
Trane Technologies
TT
$106B
| $142M | 0.19% |
364,780
+6,352
| +2% | +$2.2M |
|
62
Hamilton Lane
HLNE
$5.57B
| $132M | 0.17% |
785,301
-11,621
| -1% | -$1.68M |
|
|
63
Builders FirstSource
BLDR
$8.04B
| $128M | 0.17% |
661,976
+661,718
| +256,480% | +$110M |
|
64
Arm
ARM
$302B
| $128M | 0.17% |
896,700
-75,387
| -8% | -$10.7M |
|
65
Merit Medical Systems
MMSI
$5.32B
| $108M | 0.14% |
1,097,156
-16,894
| -2% | -$1.55M |
|
66
Procept Biorobotics
PRCT
$1.17B
| $99.6M | 0.13% |
1,243,267
-18,341
| -1% | -$1.3M |
|
67
Doximity
DOCS
$4.88B
| $99M | 0.13% |
2,272,231
-200,621
| -8% | -$6.69M |
|
68
Texas Instruments
TXN
$261B
| $98.5M | 0.13% |
477,022
-202,614
| -30% | -$40.7M |
|
69
HealthEquity
HQY
$8.75B
| $92.2M | 0.12% |
1,126,645
+24,665
| +2% | +$1.9M |
|
70
Weatherford International
WFRD
$6.22B
| $89.8M | 0.12% |
1,057,462
-51,270
| -5% | -$5.53M |
|
71
Insmed
INSM
$28.6B
| $88.3M | 0.12% |
1,210,187
-16,539
| -1% | -$1.22M |
|
72
Glaukos
GKOS
$10.6B
| $87.8M | 0.12% |
673,751
+119,527
| +22% | +$14.9M |
|
73
Arcosa
ACA
$7.11B
| $87.2M | 0.11% |
919,999
-17,147
| -2% | -$1.5M |
|
74
ATI
ATI
$31B
| $86.8M | 0.11% |
1,297,155
-219,777
| -14% | -$13.6M |
|
75
RBC Bearings
RBC
$18B
| $84.9M | 0.11% |
283,437
+7,380
| +3% | +$2.12M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2024 Portfolio in Review
As of Q3 2024, Loomis, Sayles & Company held 781 positions worth $76.2B, up 5% from $72.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Loomis, Sayles & Company's Q3 2024 filing shows 70 new, 299 increased, 299 reduced and 89 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M. The largest sale was Oracle, an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q3 2024 buy was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M.
- Loomis, Sayles & Company added most to Nike in Q3 2024, an estimated $510M increase.
- Loomis, Sayles & Company's biggest Q3 2024 reduction was Oracle, cutting an estimated $114M.
- Loomis, Sayles & Company fully exited Simply Good Foods in Q3 2024, selling an estimated $58.7M.
- Loomis, Sayles & Company's ten largest holdings make up 46% of its $76.2B portfolio in Q3 2024.
- Loomis, Sayles & Company opened 70 new positions and closed 89 in Q3 2024.
- Loomis, Sayles & Company's portfolio value rose 5% quarter-over-quarter to $76.2B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2024, filed 13 Nov 2024.